Announcements Trials
Browse Landscape

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Observational 3

Sponsor

Cancer Type

Tumor-Agnostic 2Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1Neoplasms, Second Primary 1Neoplasms 1

Interventions

Specimen Handling 481pembrolizumab 454Magnetic Resonance Spectroscopy 419Carboplatin 321Cyclophosphamide 314Biopsy 272Cisplatin 264Radiotherapy 239Paclitaxel 226Gemcitabine 222Bevacizumab 212Nivolumab 189fludarabine 183venetoclax 172Drug Therapy 165Dexamethasone 157Blood Specimen Collection 156Oxaliplatin 154Injections 152Capecitabine 152Fluorouracil 144Docetaxel 142Standard of Care 136Radiosurgery 136Rituximab 125Pemetrexed 115durvalumab 113atezolizumab 110Leucovorin 110Radiation 105

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Registries × 1 year × Clear all
NCT03413982 2026-03-10

GUB-BCR-001

University of Kansas Medical Center

Recruiting
1,000 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT04511806 2025-10-29

CCPS

Emory University

Recruiting
1,050 enrolled
Tumor-Agnostic

Neoplasms

NCT04376229 2025-07-01

Proton Radiation Therapy Registry

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Recruiting
5,000 enrolled
Tumor-Agnostic

Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡